Edesa Biotech (EDSA) Stock Statistics & Valuation Metrics

Edesa Biotech has a market cap or net worth of $12.33M. The enterprise value is $0.00.

Edesa Biotech has 8,333,823 shares outstanding. The number of shares has decreased by -2.65% in one year.

Edesa Biotech’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Edesa Biotech is ―. Edesa Biotech’s PEG ratio is 0.00.

In the last 12 months, Edesa Biotech had revenue of 0.00 and earned -7.19M in profits. Earnings per share was -1.27.

In the last 12 months, operating cash flow was -7.32M and capital expenditures 0.00, giving a free cash flow of -7.32M billion.

Edesa Biotech pays an annual dividend of ―, resulting in a dividend yield of ―

Edesa Biotech upcoming earnings date is Feb 18, 2026, After Close (Not Confirmed).

Edesa Biotech as a current ratio of ―, with Debt / Equity ratio of 0.00%

In the past 12 months, Edesa Biotech has paid 800.00 in taxes.

Edesa Biotech EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Edesa Biotech has $10.79M in cash and marketable securities with $0.00 in debt, giving a net cash position of $10.79M billion.

Gross margin is 0.00%, with operating margin of ―, and net profit margin of ―.

The average price target for Edesa Biotech is $5.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy